Tradestie Institutional Equity Comparison Engine
DXR vs INFU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
INFU Overall Edge
INFU Captures Institutional Edge (4โ0 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to InfuSystem Holdings, Inc. (INFU) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DXR trades at 64.5x Forward P/E with -5894.3% operating margin (+25.5% YoY revenue) versus INFU at 26.4x Forward P/E and 8.5% operating margin (+3.0% YoY). In options structure, DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against INFU sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
INFU
DXR 64.5x vs INFU 26.4x Fwd P/E
Growth & Margin Winner
INFU
Op Margin -5894.3% vs 8.5% ยท YoY +25.5% vs +3.0%
Momentum & Technical Winner
INFU
1Y -38.3% vs +45.6% ยท 52W Pos 2% vs 92%
Options & Structure Winner
INFU
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (7th %ile IV)
DXR
NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap
$49.5M
1M Return
-16.87%
1Y Return
-38.29%
Forward P/E
64.5x
Unified AI Score
52.2 / 100
HOLD
Tech 52.0
Fund 59.0
Flow 50.0
Mom 64.0
INFU
NYSE American
InfuSystem Holdings, Inc.
Surgical & Medical Instruments & Apparatus
$14.79
+0.48% 1D
Market Cap
$294.9M
1M Return
+10.37%
1Y Return
+45.57%
Forward P/E
26.4x
Unified AI Score
36.6 / 100
SELL
Tech 8.0
Fund 28.0
Flow 54.0
Mom 25.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DXR -38.29%
INFU +45.57%
Spread: +78.84 pp (INFU Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
DXR TTM Op. Margin: -5894.3%
INFU TTM Op. Margin: 8.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DXR vs INFU. Trailing 12-month operating profitability (DXR -5894.3% vs INFU 8.5%) and valuation multiples (DXR 64.5x vs INFU 26.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DXR | INFU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $49.5M | $294.9M | Larger Scale | INFU |
| Trailing P/E Ratio Valuation | 7.7x | 33.5x | Lower Multiple | DXR |
| Forward P/E Ratio Valuation | 64.5x | 26.4x | Lower Multiple | INFU |
| Revenue Growth (YoY) Growth | +25.5% | +3.0% | Higher Growth | DXR |
| Operating Margin (TTM) Profitability | -5894.3% | 8.5% | Higher Margin | INFU |
| Net Profit Margin Profitability | 19861.4% | 6.5% | Higher Margin | DXR |
| Return on Equity (ROE) Capital Efficiency | 14.2% | 15.8% | Higher ROE | INFU |
| 52-Week Range Position Momentum | 2% ($8โ$15) | 92% ($7โ$15) | Stronger Trend | INFU |
| Beta / 30D Volatility Risk Regime | 0.28ฮฒ ยท 32% Vol | 0.78ฮฒ ยท 48% Vol | Lower Realized Risk | DXR |
| Unified Institutional Score Composite Signal | 52.2 / 100 (HOLD) | 36.6 / 100 (SELL) | Higher Composite | DXR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DXR vs INFU Buy Guide
DXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
INFU
CONSOLIDATION
22d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DXR nor INFU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.